<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02146469</url>
  </required_header>
  <id_info>
    <org_study_id>SH2012VAR</org_study_id>
    <nct_id>NCT02146469</nct_id>
  </id_info>
  <brief_title>Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine</brief_title>
  <official_title>Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Municipal Center for Disease Control and Prevention</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Institute Of Biological Products</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Municipal Center for Disease Control and Prevention</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is as follows:

        1. To know the antibody level during different interval after received 1 dose varicella
           vaccine.

        2. To know safety and effectiveness of received 2 doses varicella vaccine with different
           interval.

        3. To know safety and effectiveness of received varicella vaccine and MMR at the same time.

      To achieve that, this study selects children with specific varicella vaccine history, gives 1
      or 2 doses varicella vaccine, collects blood specimens and makes a follow-up visit after
      vaccination.

      All blood specimens will be tested by a third-party detection institution.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Seroconversion rate and GMCs after varicella vaccination</measure>
    <time_frame>35-42 days after each dose vaccination</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of Adverse Events Following Immunization</measure>
    <time_frame>30 days after each dose vaccination</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Varicella</condition>
  <arm_group>
    <arm_group_label>None varicella vaccine history</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 doses with an 3 months interval</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1 year after first dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A second dose with an 1 year interval</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 years after first dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A second dose with an 3 year interval</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5 years after first dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A second dose with an 5 year interval</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Testing group for conbined immunization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 dose Varicella vaccine and 1 dose MMR given at the same time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group for conbined immunization</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1 dose MMR</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>2 doses with an 3 months interval</intervention_name>
    <description>varicella vaccination</description>
    <arm_group_label>None varicella vaccine history</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>A second dose with an 1 year interval</intervention_name>
    <description>varicella vaccine</description>
    <arm_group_label>1 year after first dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>A second dose with an 3 year interval</intervention_name>
    <description>varicella vaccine</description>
    <arm_group_label>3 years after first dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>A second dose with an 5 year interval</intervention_name>
    <description>varicella vaccine</description>
    <arm_group_label>5 years after first dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>1 dose Varicella vaccine and 1 dose MMR given at the same time</intervention_name>
    <description>varicella vaccine and MMR</description>
    <arm_group_label>Testing group for conbined immunization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>1 dose MMR</intervention_name>
    <description>MMR</description>
    <arm_group_label>Control group for conbined immunization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 1 to 7

          -  Without a previous history of varicella

          -  With an axillary temperature ≤37.5℃ at the time of vaccination

          -  Appropriate varicella vaccination history

          -  With guardian signing the informed consent and available for clinical observation

        Exclusion Criteria:

          -  Hypersensitive to any active substance of the vaccine including excipients and
             antibiotics

          -  With acute illness, severe or acute attack of chronic illness or fever

          -  With immunodeficiency or weakened immune system or being treated with
             immunosuppressant drugs

          -  Suffering a brain disease, uncontrolled epilepsy or progressive nerve system disease

          -  With a family or personal history of seizure, chronic illness, epilepsy or allergy

          -  With unknown immunization history or unable to follow the immunization schedule of EPI

          -  Received any vaccine within 4 weeks or willing to receive any vaccine in 1 month

          -  With hemorrhagic tendency or prolonged period of bleeding

          -  Received whole blood, plasma or immunoglobulin within 5 months

          -  Received systemic antibiotics or antiviral treatment for acute illness within 7 days

          -  With an axillary temperature ≥38℃ within 3 days

          -  Participating in another clinical trial

          -  Any situation that might influence the consequence of the clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaodong Sun</last_name>
    <role>Study Director</role>
    <affiliation>Shanghai Municipal Center for Disease Control and Prevention</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shanghai municipal center for disease control and prevention</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2014</study_first_submitted>
  <study_first_submitted_qc>May 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 23, 2014</study_first_posted>
  <last_update_submitted>May 21, 2014</last_update_submitted>
  <last_update_submitted_qc>May 21, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>varicella vaccination</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chickenpox</mesh_term>
    <mesh_term>Herpes Zoster</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

